You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antineoplastic Agents, Hormonal

Showing 1 - 25 of 8,343
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Based Discrete Choice Experiment Study in Prostate Cancer Study

Completed
  • Prostate Cancer
  • Metastatic Hormone-sensitive Prostate Cancer
    • Durham, North Carolina
      Duke Clinical Research Institute
    Jan 10, 2023

    Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

    Not yet recruiting
    • Neoplasms
    • +2 more
    • Nivolumab Injection [Opdivo]
    • (no location specified)
    Jul 19, 2023

    Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

    Not yet recruiting
    • Carcinoma
    • +7 more
    • (no location specified)
    Nov 12, 2023

    Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in

    Recruiting
    • Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
    • Columbus, Ohio
    • +9 more
    Aug 1, 2022

    Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

    Recruiting
    • Hormone Receptor Positive Breast Carcinoma
    • +6 more
    • Liquid biopsy and CT scan
    • Bergame, Bergamo, Italy
    • +6 more
    Apr 13, 2023

    Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)

    Recruiting
    • Metastatic Prostate Cancer
    • San Diego, California
    • +25 more
    Jan 10, 2023

    Endometriosis, Pelvic Pain Trial in Ribeirão Preto (Cannabis Derivatives, Placebo, Hormonal Contraceptive Agents)

    Enrolling by invitation
    • Endometriosis
    • Pelvic Pain
    • Cannabis Derivatives
    • +2 more
    • Ribeirão Preto, Sao Paulo, Brazil
      Center of Chronic Pelvic Pain and Gynecologic Endoscopy of Ribei
    Dec 20, 2022

    NSCLC, Antineoplastic Agents Trial in Edmonton (Experimental intervention)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Antineoplastic Agents
    • Experimental intervention
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    May 23, 2022

    Carcinoma Prostate Trial in Brescia (Cabozantinib)

    Recruiting
    • Carcinoma Prostate
    • Brescia, Italy
      Alfredo Berruti
    Mar 2, 2022

    Prostate Cancer Trial in Bellinzona (Lifestyle intervention)

    Not yet recruiting
    • Prostate Cancer
    • Lifestyle intervention
    • Bellinzona, Switzerland
      Oncology Institute of Southern Switzerland (IOSI)
    May 5, 2023

    Reporting of Antibody-Drug Conjugate Associated Sepsis-related

    Completed
    • Sepsis (SMQ)
    • +2 more
    • Antibody-Drug Conjugate
    • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
    • Changsha, Hunan, China
      Central South University
    Jun 19, 2022

    Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

    Recruiting
    • Neoplasms
    • +12 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Oct 28, 2023

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

    Recruiting
    • Leukemia
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +9 more
    Sep 9, 2022

    Prostate Cancer Metastatic, Prostate Cancer Trial in Worldwide (ODM-201, Placebo)

    Active, not recruiting
    • Prostate Cancer Metastatic
    • Prostate Cancer
    • Bordeaux, France
    • +31 more
    Mar 18, 2022

    Reporting of AdVerse Events Associated With AnTicAncerRapy

    Recruiting
    • Cancer
    • Antineoplastic and Immunomodulating Agents
    • Caen, Basse Normandie, France
      Alexandre Joachim
    Jan 4, 2021

    Urinary Bladder Tumors, Urologic Tumors, Urogenital Tumors Trial in Shanghai (tislelizumab and BCG)

    Recruiting
    • Urinary Bladder Neoplasms
    • +5 more
    • tislelizumab and BCG
    • Shanghai, Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Jun 10, 2021

    Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

    Active, not recruiting
    • Multiple Myeloma
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +8 more
    May 24, 2022

    Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)

    Not yet recruiting
    • Female Breast Cancer
    • Hormonal Antineoplastics
    • Chemotherapy drug
    • Sohag, Egypt
      amal Ali
    Feb 23, 2023

    Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Marina Del Rey, California
    • +35 more
    Mar 11, 2022

    Urothelial Carcinoma, Anlotinib, Urogenital Tumors Trial in Tianjin (Anlotinib, Cisplatin, Carboplatin)

    Not yet recruiting
    • Urothelial Carcinoma
    • +6 more
    • Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Aug 30, 2021

    Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

    Recruiting
    • Lung Neoplasm Malignant
    • +18 more
    • Fairfax, Virginia
      New Experimental Therapeutics of Virginia (NEXT Oncology)
    Mar 29, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +6 more
    • San Francisco, California
      University of California, San Francisco
    Sep 8, 2022

    Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,

    Not yet recruiting
    • Carcinoma
    • +8 more
    • Hepatic arterial infusion chemotherapy
    • +2 more
    • Guangzhou, Guangdong, China
      Lei Zhang
    Sep 22, 2021